Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

SSY Group Limited Board/Management Information 2021

Aug 27, 2021

50335_rns_2021-08-27_f88af368-b6a3-4b2a-a16e-10440ca583bc.pdf

Board/Management Information

Open in viewer

Opens in your device viewer

Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited take no responsibility for the contents of this announcement, make no representation as to its accuracy or completeness and expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon the whole or any part of the contents of this announcement.

==> picture [250 x 53] intentionally omitted <==

(Incorporated in the Cayman Islands with limited liability)

(Stock Code: 2005)

APPOINTMENT AND RESIGNATION OF EXECUTIVE DIRECTORS

  • The Board announced that, with effect from 27 August 2021:
  1. Mr. Meng Guo and Mr. Chow Hing Yeung have been appointed as executive Directors;

  2. Mr. Wang Xianjun has resigned as an executive Director due to his desire to retire; and

  3. Mr. Wang Xianjun has ceased to act as an Authorised Representative and Mr. Meng Guo was appointed as an Authorised Representative.

APPOINTMENT OF EXECUTIVE DIRECTORS

The board (the “ Board ”) of directors (the “ Director(s) ”) of SSY Group Limited (the “ Company ”, together with its subsidiaries, the “ Group ”) is pleased to announce that Mr. Meng Guo (“ Mr. Meng ”) and Mr. Chow Hing Yeung (“ Mr. Chow ”) have been appointed as executive Directors of the Company with effect from 27 August 2021. Mr. Meng has also been appointed as an authorised representative (the “ Authorised Representative ”) of the Company under Rule 3.05 of the Rules Governing the Listing of Securities (the “ Listing Rules ”) on The Stock Exchange of Hong Kong Limited (the “ Stock Exchange ”) with effect from 27 August 2021.

— 1 —

The biographical details of Mr. Meng and Mr. Chow are set out as below:

Mr. Meng Guo , aged 47, is currently the deputy general manager of the Company, a director of New Orient Investments Pharmaceutical Holding (Hong Kong) Limited and 石家莊四藥有限公司 (Shijiazhuang No. 4 Pharmaceutical Co., Ltd.) (“ Shijiazhuang No. 4 ”) and 河北國龍製藥有限公司 (Hebei Guolong Pharmaceutical Co., Ltd.), all being wholly-owned subsidiaries of the Company, and the executive president in charge of finance and information-based operations of Shijiazhuang No. 4. After joining Shijiazhuang No. 4 in year 2001, Mr. Meng held the positions of deputy head and manager of the finance department of Shijiazhuang No. 4, and has over 20 years of experience in corporate finance, tax and information technology management. Mr. Meng has consistently participated in investors’ relations duties of the Company throughout his term of service. Mr. Meng holds a Bachelor’s degree in Mathematics from Lanzhou University and a Master’s degree in Software Engineering from Beijing University of Technology. He also holds the qualification of senior accountant in the People’s Republic of China.

Mr. Chow Hing Yeung , aged 42, is currently the Chief Financial Officer and Company Secretary of the Company. Mr. Chow obtained a Bachelor’s degree of Business Administration from the Chinese University of Hong Kong. Before joining the Company in August 2011, he worked in PricewaterhouseCoopers and financial department of listed companies in Hong Kong, and has around 20 years of experience in audit, accounting and financial management. Mr. Chow has consistently participated in investors’ relations duties of the Company throughout his term of service. He is a member of the Hong Kong Institute of Certified Public Accountants.

Each of Mr. Meng and Mr. Chow has entered into a service agreement with the Company in respect of their directorships and their existing positions with the Group for a term of three years, and their appointments as directors are subject to retirement by rotation and re-election at the upcoming annual general meeting of the Company in accordance with the articles of association of the Company. Under their respective service agreements, both Mr. Meng and Mr. Chow will not receive any directors’ fee but Mr. Meng will be entitled to a basic salary of HK$1,000,000 per annum and discretionary bonus and Mr. Chow will be entitled to a basic salary of HK$1,100,000 per annum and discretionary bonus, in which discretionary bonus are to be determined on the recommendation of the remuneration committee of the Company and with reference to their respective duties and responsibilities within the Group and the prevailing market conditions.

Save as disclosed above, Mr. Meng and Mr. Chow have confirmed that they do not hold (i) any other position with the Company or other members of the Group; (ii) any directorship in any other public companies the securities of which are listed on any securities market in Hong Kong or overseas in the last three years; and (iii) any other major appointments and professional qualifications.

As at the date of this announcement, Mr. Meng and Mr. Chow have interests in share options granted on 12 January 2021 under the share option scheme adopted by the Company on 20 September 2012, which entitles Mr. Meng to subscribe for 20,000,000 ordinary shares and Mr. Chow to subscribe for 2,000,000 ordinary shares in the share capital of the Company, respectively.

— 2 —

As at the date of this announcement, Mr. Meng and Mr. Chow have confirmed that save as disclosed above, (i) they do not have, and is not deemed to have any interests in any shares of the Company within the meaning of Part XV of the Securities and Futures Ordinance (Chapter 571 of the Laws of Hong Kong); and (ii) they do not have any relationship with any Director, senior management or substantial or controlling shareholders of the Company.

Save as disclosed above, there is no information relating to Mr. Meng and Mr. Chow that is required to be disclosed pursuant to Rules 13.51(2)(h) to (v) of the Listing Rules and there is no other matter in relation to the appointments of Mr. Meng and Mr. Chow that needs to be brought to the attention of the shareholders of the Company and the Stock Exchange.

The Company would like to take this opportunity to express its warmest welcome to Mr. Meng and Mr. Chow on joining the Board.

RESIGNATION OF EXECUTIVE DIRECTOR

The Board announces that Mr. Wang Xianjun (“ Mr. Wang ”) has resigned as an executive Director and all his other positions with the Company with effect from 27 August 2021 due to his desire to retire at the age of 59. Mr. Wang has also ceased to act as an Authorised Representative.

Mr. Wang has confirmed that he has no disagreement with the Board and there are no matters that need to be brought to the attention of the Stock Exchange or/and the shareholders of the Company in relation to his resignation.

The Board would like to take this opportunity to express its sincere appreciation to Mr. Wang for his valuable contributions to the Company during his tenure of office.

By Order of the Board

Chow Hing Yeung

Executive Director and Company Secretary

Hong Kong, 27 August 2021

As at the date of this announcement, the Board comprises Mr. Qu Jiguang, Mr. Su Xuejun, Mr. Meng Guo and Mr. Chow Hing Yeung as executive Directors, Mr. Feng Hao as non-executive Director and Mr. Wang Yibing, Mr. Leung Chong Shun and Mr. Chow Kwok Wai as independent non-executive Directors.

  • for identification purpose only

— 3 —